Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA.
J Am Chem Soc. 2012 Oct 10;134(40):16765-72. doi: 10.1021/ja307207q. Epub 2012 Sep 26.
Total syntheses of HMP-Y1, atrop-HMP-Y1, hibarimicinone, atrop-hibarimicinone, and HMP-P1 are described using a two-directional synthesis strategy. A novel benzyl fluoride Michael-Claisen reaction sequence was developed to construct the complete carbon skeleton of HMP-Y1 and atrop-HMP-Y1 via a symmetrical, two-directional, double annulation. Through efforts to convert HMP-Y1 derivatives to hibarimicinone and HMP-P1, a biomimetic mono-oxidation to desymmetrize protected HMP-Y1 was realized. A two-directional unsymmetrical double annulation and biomimetic etherification was developed to construct the polycyclic and highly oxidized skeleton of hibarimicinone, atrop-hibarimicinone, and HMP-P1. The use of a racemic biaryl precursor allowed for the synthesis of both hibarimicinone atropisomers and provides the first confirmation of the structure of atrop-hibarimicinone. Additionally, this work documents the first reported full characterization of atrop-hibarimicinone, HMP-Y1, atrop-HMP-Y1, and HMP-P1. Last, a pH-dependent rotational barrier about the C2-C2' bond of hibarimicinone was discovered, which provides valuable information necessary to achieve syntheses of the glycosylated congeners of hibarimicinone.
采用双向合成策略,描述了 HMP-Y1、atrop-HMP-Y1、hibarimicinone、atrop-hibarimicinone 和 HMP-P1 的全合成。开发了一种新颖的苄基氟化物迈克尔-克来森反应序列,通过对称的、双向的、双环加成反应构建了 HMP-Y1 和 atrop-HMP-Y1 的完整碳骨架。通过努力将 HMP-Y1 衍生物转化为 hibarimicinone 和 HMP-P1,实现了保护的 HMP-Y1 的仿生单氧化去对称化。发展了一种双向不对称双环加成和仿生醚化反应,构建了 hibarimicinone、atrop-hibarimicinone 和 HMP-P1 的多环和高度氧化骨架。使用外消旋联芳基前体允许合成 hibarimicinone 的两种对映异构体,并首次确认了 atrop-hibarimicinone 的结构。此外,这项工作记录了对 atrop-hibarimicinone、HMP-Y1、atrop-HMP-Y1 和 HMP-P1 的首次全特征描述。最后,发现了 hibarimicinone 中 C2-C2' 键的 pH 依赖性旋转势垒,这为实现 hibarimicinone 的糖基化类似物的合成提供了必要的有价值信息。